Case Study: Stage IV Precision Pancreatic Adenocarcinoma Cancer Treatment
Dr. Dino Prato and Dr. John Oertle review a stage 4 pancreatic adenocarcinoma case. Pancreatic cancers are known to have poor prognostics with a dismal survival rate, even with some of the standard treatment options like Whipple procedure. However, not every patient is an ideal candidate for Whipple procedure, which further limits their options. At Envita, we aim to widen the tool kit of options for our patients by allowing access to personalized precision oncology treatments, giving them an optimal chance at fighting for their lives.
Learn how Envita Medical Centers' advanced precision oncology was deployed to help this patient respond to care.
Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient case is unique. Please consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or achieves these results. Treatments used in this case may not all be FDA approved for the treatment of this condition.
